Neuroprotection of α-synuclein under acute and chronic rotenone and maneb treatment is abolished by its familial Parkinson's disease mutations A30P, A53T and E46K. (Q39527730)
Jump to navigation
Jump to search
scientific article published on 30 May 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Neuroprotection of α-synuclein under acute and chronic rotenone and maneb treatment is abolished by its familial Parkinson's disease mutations A30P, A53T and E46K. |
scientific article published on 30 May 2011 |
Statements
Neuroprotection of α-synuclein under acute and chronic rotenone and maneb treatment is abolished by its familial Parkinson's disease mutations A30P, A53T and E46K (English)